|
|
Research Paper
|
|
|||
Acta Biochim Biophys Sin 2005,37:613-617 |
||||
doi:10.1111/j.1745-7270.2005.00085.x |
Expression, Purification and
Crystal Structure of a Truncated Acylpeptide Hydrolase from Aeropyrum
pernix K1
Hai-Feng ZHANG, Bai-Song
ZHENG1,
Ying PENG, Zhi-Yong LOU, Yan FENG1*,
and Zi-He RAO*
Laboratory of Structural Biology,
Department of Biological Sciences and Biotechnology and Protein Sciences Laboratory
of Ministry of Education, Tsinghua University, Beijing 100084, China
1 Key Laboratory for Molecular Enzymology and
Engineering of Ministry of Education,
Received:
March 20, 2005
Accepted:
June 7, 2005
*Corresponding
authors:
Yan
FENG: Tel, 86-431-8987975; E-mail, [email protected]
Zi-He
RAO: Tel, 86-10-62771493; Fax, 86-10-62773145; E-mail,
[email protected]
Abstract Acylpeptide
hydrolase (APH) catalyzes the N-terminal hydrolysis of Na-acylpeptides to release Na-acylated
amino acids. The crystal structure of recombinant APH from the thermophilic
archaeon Aeropyrum pernix K1 (apAPH) was reported recently to be at a
resolution of 2.1 Å using X-ray diffraction. A truncated mutant of apAPH that
lacks the first short a-helix at the
N-terminal, apAPH-D(1-21), was
cloned, expressed, characterized and crystallized. Data from biochemical experiments
indicate that the optimum temperature of apAPH is decreased by 15 ºC with the
deletion of the N-terminal a-helix.
However, the enzyme activity at the optimal temperature does not change. It
suggests that this N-terminal a-helix is
essential for thermostability. Here, the crystal structure of apAPH-D(1-21) has been determined by molecular
replacement to
Key words
acylpeptide hydrolase; Aeropyrum pernix K1; crystal structure
Acylpeptide hydrolase
(APH; also known as acylamino acid-releasing enzyme or acylaminoacyl peptidase
[EC
To date, rat, porcine,
human and bovine APH from various tissues have been characterized. They all
consist of 732 amino acid residues, and were reported to form homotetramers
[48]. However, Arabidopsis thaliana APH is a 764-amino acid protein, which
exhibits 31.8% sequence identity with rat APH, and it also forms a tetramer
[9]. An APH from the thermophilic archaeon Pyrococcus horikoshii OT3 has
also been characterized. Being different from its mammalian counterparts, it is
100 residues shorter and forms a homodimer [10]. Inhibition of APH activity
leads to apoptosis [11], and a deficiency in human APH is reported to be
linked to small-cell lung carcinoma and renal cell carcinoma [1214]. APH in
the porcine brain may be the target of the cognitive-enhancing effects of
certain organophosphorus compounds [15].
Like P. horikoshii
OT3, Aeropyrum pernix K1 grows in the temperature range of 90 to 98 ºC,
with an optimal temperature of 95 ºC. However, P. horikoshii OT3 is an
anaerobic euryarchaeota, and A. pernix K1 is an aerobic strain
classified as crenarchaeota. The complete genome of A. pernix K1 has
been sequenced, and four genes (Ape1547, Ape1832, Ape2290
and Ape2441) have been designated as encoding APHs [16]. Recently, the
crystal structure of an APH from A. pernix K1 (apAPH), the gene product
of Ape1547, was determined [17]. This is the first confirmed structure
of an APH. Formerly, only human APH has been crystallized, but the structure
remains unknown [18].
apAPH is a symmetric
homodimer, and each monomer comprises two domains. The N-terminal domain is a
seven-bladed b-propeller
and the C-terminal catalytic domain has a canonical a/b hydrolase
fold [17]. A short a-helix at the
N-terminus (residues 823) extends from the b-propeller domain and forms part of the hydrolase domain;
this forms a linking structure between these two domains.
To investigate how this
N-terminal a-helix
affects the whole structure, enzyme activity and thermostability, a mutant of
apAPH in which the first 21 amino acids at the N-terminus were removed, apAPH-D(1-21), was expressed in Escherichia coli,
and its crystal structure was determined.
Materials and Methods
Materials
The expression vector pET
Protein expression and
purification
The expression vector pET
Crystallization
The purified protein was
concentrated using Filtron 5K to 25 mg/ml in a solution containing
Data collection and
processing
The data were collected
to 2.5 Å using a
Results
Structure determination and
refinement
The asymmetric unit of
the crystal contains two molecules (denoted A and B) with an approximate
solvent content of 44%. The structure of apAPH-D(1-21) was determined by molecular replacement with the
program AMoRe, using the known structure of apAPH (PDB code 1VE6) as a search
model. The program O was used for viewing electron density maps and manual
building. Crystallography & NMR system (CNS) was used for refinement, with
iterative cycles of simulated annealing and individual B-factor refinement in
the resolution range of 502.5 Å. The final structure had Rwork=22.9% (Rfree=24.8%), and consisted
of 561 residues in molecule A and molecule B respectively and 579 water
molecules. From the Ramachandran plot generated by PROCHECK, the final structure
was found to have good stereochemistry, with 73.8% of residues in the most
favored region, 26% of residues in the additionally allowed region and 0.2% of
residues in the generously allowed region. The final refinement statistics for
the model are given in Table 1.
Comparison with apAPH
Enzymatic assay data
indicate that the optimum temperature of apAPH is decreased by 15 ºC (from 90
ºC to 75 ºC) with the deletion of the N-terminal a-helix, but the enzyme activity at the optimal
temperature does not change (data not shown). It suggests that this a-helix is essential for thermostability. Fig. 1
shows the superposition of the Ca backbones of apAPH-D(1-21) and wild-type apAPH. The main-chain
conformations of them are very similar, except for the a-helix at the N-terminus. The root mean square (r.m.s.)
deviation of all the main-chain atoms (calculated against molecule A) between
the two structures is 0.873 Å. When the two domains are calculated separately,
the r.m.s. deviations are 0.801 Å for the N-terminal domain and 0.829 Å for the
C-terminal domain. It can be inferred that there are further differences
between the C-terminal catalytic domains of two structures.
The structure of apAPH-D(1-21) is more flexible. The average B-factor
values are 32.5 Å2 for apAPH-D(1-21) and 19.4 Å2 for apAPH respectively. It should be noted that
the temperature factors are considerably higher for apAPH-D(1-21), indicating greater mobility along the
polypeptide chain in this structure (Fig. 2).
Analysis of the electrostatic
surface of apAPH-D(1-21)
revealed that an additional cavity forms where the N-terminal a-helix existed (Fig. 3). It is believed
that the cavity in the electrostatic surface is a disadvantage for protein
stability.
Discussion
apAPH is a bifunctional
enzyme, acting as both APH and esterase. Esterases have developed into the most
widely used classes of enzymes in various industrial processes, including
stereospecific hydrolysis, transesterification, ester synthesis and modification
of physicochemical properties of triglycerides for fat biosynthesis and other
organic biosynthesis reactions. However, mesophilic enzymes are often not well
suited for the harsh reaction conditions, such as high temperature, exposure to
organic solvents, etc., in industrial processes because of the lack of enzyme
stability. The discovery of a specific esterase able to function under extreme
conditions is important and will widely extend the range of reactions in which
esterase can be used. Experiments indicate that apAPH has esterase activity in
the temperature range of 55 to 95 ºC, with maximum activity and highest
thermostability at 90 ºC (data not shown).
In general, several
factors are known to affect the stability of thermophilic proteins. Primary
sequence composition, salt bridge/ion pairs and hydrogen bonds, hydrophobic
interaction contact area and solvent accessible surface area all contribute to
thermostability. In this study, a specific method has been applied and as a
result of this, a new method of changing the thermostability of an enzyme to a
great extent has been discovered.
In contrast with the
percentage of the first 21 amino acids in the total of 582 amino acids (3.6%),
the percentages of charged and hydrophobic residues in the truncated sequence
are 5.1% and 5.2% respectively. Macroscopically, an increase in the number of
charged and hydrophobic residues can enhance thermostability. In addition,
there are two important salt bridges (D15-R355 and R18-D325) which also improve
the thermal stability. In general, it is believed that a decrease in the
solvent-accessible surface area is favorable for protein stability, and the
larger cavity results in an increase in solvent accessibility of the structure
and thus reduces thermostability. But these values are 20,955 Å2 for apAPH and 20,289 Å2 for apAPH-D(1-21).
Therefore, the cavity may influence thermostability in other ways.
In conclusion, the
decrease in thermostability appears to the result of amino acid composition,
fewer ionic interactions and a larger cavity in the structure. Together, these
structural features may serve to enhance the thermostability of apAPH.
However, as the N-terminal a-helix has no
effect on the active site, the enzyme activity of apAPH-D(1-21) is the same as that of the wild-type apAPH.
Moreover, the structural comparison above suggests that we can change the
stability of an enzyme and at the same time retain its activity by adding or
deleting a linking structure (located over different domains). A quick modification
based on structure is thus possible.
References
1 Tsunasawa S, Narita K, Ogata K.
Purification and properties of acylamino acid-releasing enzyme from rat liver.
J Biochem (
2 Polgar L. The prolyl oligopeptidase
family. Cell Mol Life Sci 2002, 59: 349-362
3 Rosenblum JS, Kozarich JW. Prolyl
peptidases: A serine protease subfamily with high potential for drug discovery.
Curr Opin Chem Biol 2003, 7: 496-504
4 Kobayashi K, Lin LW, Yeadon JE,
Klickstein LB, Smith JA. Cloning and sequence analysis of a rat liver cDNA
encoding acyl-peptide hydrolase. J Biol Chem 1989, 264: 8892-8899
5 Mitta M, Asada K, Uchimura Y, Kimizuka F,
Kato I, Sakiyama F, Tsunasawa S. The primary structure of porcine liver
acylamino acid-releasing enzyme deduced from cDNA sequences. J Biochem (
6 Miyagi M, Sakiyama F, Kato I, Tsunasawa
S. Complete covalent structure of porcine liver acylamino acid-releasing enzyme
and identification of its active site serine residue. J Biochem (
7 Mitta M, Ohnogi H, Mizutani S, Sakiyama
F, Kato I, Tsunasawa S. The nucleotide sequence of human acylamino
acid-releasing enzyme. DNA Res 1996, 3: 31-35
8 Sharma KK, Ortwerth BJ. Bovine lens acylpeptide
hydrolase. Purification and characterization of a tetrameric enzyme resistant
to urea denaturation and proteolytic inactivation. Eur J Biochem 1993, 216: 631-637
9 Yamauchi Y, Ejiri Y, Toyoda Y, Tanaka K.
Identification and biochemical characterization of plant acylamino
acid-releasing enzyme. J Biochem (
10 Ishikawa K, Ishida H, Koyama Y,
Kawarabayasi Y, Kawahara J, Matsui E, Matsui I. Acylamino acid-releasing enzyme
from the thermophilic archaeon Pyrococcus horikoshii. J Biol Chem 1998,
273: 17726-17731
11 Yamaguchi M, Kambayashi D, Toda J,
Sano T, Toyoshima S, Hojo H. Acetylleucine chloromethyl ketone, an inhibitor of
acylpeptide hydrolase, induces apoptosis of U937 cells. Biochem Biophys Res
Commun 1999, 263: 139-142
12 Naylor SL, Marshall A, Hensel C,
13 Scaloni A, Jones W, Pospischil M,
Sassa S, Schneewind O, Popowicz AM, Bossa F et al. Deficiency of
acylpeptide hydrolase in small-cell lung carcinoma cell lines. J Lab Clin Med
1992, 120: 546-552
14 Erlandsson R, Boldog F, Persson B, Zabarovsky
ER, Allikmets RL, Sumegi J, Klein G et al. The gene from the short arm
of chromosome 3, at D
15 Richards PG, Johnson MK, Ray DE.
Identification of acylpeptide hydrolase as a sensitive site for reaction with
organophosphorus compounds and a potential target for cognitive enhancing
drugs. Mol Pharmacol 2000, 58: 577-583
16 Kawarabayasi Y, Hino Y, Horikawa H,
Yamazaki S, Haikawa Y, Jin-No K, Takahashi M et al. Complete genome
sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix
K1. DNA Res 1999, 6: 83101, 145-152
17 Bartlam M, Wang G, Yang H, Gao R,
Zhao X, Xie G,
18 Feese M, Scaloni
A, Jones WM, Manning JM, Remington SJ. Crystallization and preliminary X-ray
studies of human erythrocyte acylpeptide hydrolase. J Mol Biol 1993, 233: 546-549